Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat for intrahepatic cholestasis of pregnancy
ISRCTN96633506Phase 2Recruiting
- Sponsor
- Imperial College London
- Start
- Aug 2026
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of maralixibat in intrahepatic cholestasis of pregnancy (ICP), sponsored by Imperial College London. Primary endpoint: Safety and tolerability. Started Aug 2026; status: recruiting.
02
Drugs
maralixibat
03
Conditions
intrahepatic cholestasis of pregnancy (ICP)
Beyond the preview
Go deeper on ISRCTN96633506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96633506.